SARAH BOUJIDA: Open Payments
NPI 1104409093 · PORT JEFFERSON STATION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 87 payments from 21 companies in 2025. Trend: 2023 $1,792 · 2024 $2,614 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $537 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $213 |
| PFIZER INC. | 14 | $173 |
| Galderma Laboratories, L.P. | 2 | $171 |
| Madrigal Pharmaceuticals | 6 | $162 |
| Ardelyx, Inc. | 7 | $160 |
| QOL Medical, LLC | 3 | $94 |
| GENZYME CORPORATION | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $69 |
| Janssen Biotech, Inc. | 3 | $58 |
Products named: XIFAXAN, MAVYRET, RINVOQ, XELJANZ, REZDIFFRA, IBSRELA, DUPIXENT, Sucraid.
Industry payments across NY — which companies pay providers there.
